Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
about
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?Diabetic Macular Edema Pathophysiology: Vasogenic versus InflammatoryAge-Related Macular Degeneration and Intracrine Biology: An HypothesisDown-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5Hypoxia-induced upregulation of pigment epithelium-derived factor by retinal glial (Müller) cellsLeukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathyKallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakagePigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cellsExpression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurityCurrent and future pharmacological intervention for diabetic retinopathy.Novel method for expression and purification of human pigment epithelium-derived factor with biological activities in Escherichia coli.Differentiation of smooth muscle progenitor cells in peripheral blood and its application in tissue engineered blood vesselsIdentification of the antivasopermeability effect of pigment epithelium-derived factor and its active site.Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis)Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1.The potential of nanomedicine therapies to treat neovascular disease in the retina.Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cellsEfficient gene transfer to retinal pigment epithelium cells with long-term expression.Targeting Neovascularization in Ischemic Retinopathy: Recent AdvancesEffects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferationNicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMDPigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cellsIdentification of a novel inhibitor of the canonical Wnt pathway.Angiogenesis in diabetes and obesityCritical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.Attenuation of choroidal neovascularization by histone deacetylase inhibitor.Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice.Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathyGrowth factors and protein kinase C inhibitors as novel therapies for the medical management diabetic retinopathy.VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathyUnderstanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients.Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.Estrogen-induced retinal endothelial cell proliferation: possible involvement of pigment epithelium-derived factor and phosphoinositide 3-kinase/mitogen-activated protein kinase pathways.Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
P2860
Q26745606-10FFE17F-826E-4B8E-A699-3B886096210AQ28070894-16B39D46-BFE1-475E-97CE-8056B1077454Q28072590-05295192-DB04-4E8C-8472-2A06C3649DD5Q28215072-33AE2C7C-64A9-47A4-A818-DF7883412281Q28572018-6A5DB32A-A795-446E-834F-F743A7F29906Q28576755-C20ACF91-8275-4C8C-A233-9C87A4C01799Q28577418-D278E961-D0CF-479F-9F2D-9E7D5997E170Q28582865-4807A7D0-D3BF-431B-83E0-A5FDC15A1BE5Q28583644-49225465-9719-4A52-8695-453DF0F85C0CQ33216425-EA00BE2C-C50A-4F2E-B144-5E343B724882Q33235324-48A53F8E-97FB-4A96-8E69-B6A8AE8A5549Q33391493-FAE66B06-4E25-4460-B1F7-B2EC3068761AQ33696019-23140586-B901-49EF-8B83-DEE2D2838882Q33787955-0E2A45D9-7E26-443E-B61F-9F783E57311FQ33808055-F42FA12B-F5EE-453A-8F1F-7E5F7A487A09Q33815623-4ABC82C0-75F0-48FD-8ADC-265F15CCB437Q33993206-137E9923-EE3A-41B3-9B1D-5825EA28B439Q34220590-5C813CB3-4D3E-407D-86F6-31C6B33B98BAQ34249929-FC16DDD9-6374-4349-A572-B9C6EBD70362Q34406695-1279E1F4-CB98-4280-92B5-0330EF198B97Q34972210-17D294DE-77EB-444C-9339-D6D48EEA0840Q35024239-CF4609F1-3E2D-44E2-AF1C-6DBBFEAC7827Q35027712-D3F1600E-8040-4883-8D3D-5AF552D64CCAQ35034418-CC211449-2990-4570-9497-379BE134D9AEQ35075647-4BF55349-C510-4A5E-AD7B-E7ADE8D63CC1Q35094199-36616F65-BA2D-4845-9656-EEAE551BAE3BQ35096644-CB067989-AFEB-4C96-A650-11D5F9AC22A1Q35153884-FAAB144F-762B-4A0F-9126-721E4406C74CQ35166644-BD896DDA-43DB-4134-BBCA-375B4E92F482Q35217263-27A31AFE-83EF-4884-9695-5D0C1FF60490Q35402696-28D04233-3A1D-4B94-A57F-DCF90806D869Q35592079-AD936A13-D911-424E-866E-57FEFAB5B165Q35648554-86F3EF13-54FC-4446-8581-5214E32075AEQ35688115-828BB6BB-E882-45D6-87AC-91C5CC380109Q35768511-87993943-638A-4D1A-8709-8B8478B6B1C7Q36083881-82AB71A6-CBB5-4C0B-A1F1-6AA7574619F4Q36194403-0BC21626-E4E1-4542-A3C8-99970561EAD8Q36458943-EF4A5038-BD2D-4B45-9278-0A47AFAF54DCQ36554012-73C4E27C-C193-4CF1-83CB-FF425A8AAACFQ36618068-B6C4DAE1-1165-44C3-AE42-B45289BF91D7
P2860
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@ast
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@en
type
label
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@ast
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@en
prefLabel
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@ast
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@en
P2093
P2860
P1433
P1476
Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
@en
P2093
P2860
P304
P356
10.1016/S0014-5793(01)02110-X
P407
P577
2001-02-01T00:00:00Z